CSIMarket
 
Quantum Biopharma Ltd   (NASDAQ: HUGE)
 

Quantum Biopharma Ltd's Suppliers Performance

HUGE's Supply Chain




 
HUGE Costs vs Sales of Suppliers Growth

More on HUGE Suppliers






Quantum Biopharma Ltd's Comment on Supply Chain


The Corporation engages contract manufacturers and contract research organizations (CROs) including Ingenu, BioPharma Services Inc., Erythro Pharma Ltd., Corealis Pharma Inc., Adgyl Lifesciences, and Vibrant Pharma to support its preclinical studies and chemical compound manufacturing. The Corporation is not dependent on these third-party providers and does not anticipate difficulties in securing alternative service providers if necessary. None of the CRO agreements permit use of the Corporation's intellectual property for their own purposes. The Corporation's research and development activities comply with regulations in Canada, Australia, and the United States. Intellectual property is protected through patent applications, trade secrets, and international patent applications filed under the Patent Cooperation Treaty (PCT).

Quantum Biopharma Ltd's Comment on Supply Chain


The Corporation engages contract manufacturers and contract research organizations (CROs) including Ingenu, BioPharma Services Inc., Erythro Pharma Ltd., Corealis Pharma Inc., Adgyl Lifesciences, and Vibrant Pharma to support its preclinical studies and chemical compound manufacturing. The Corporation is not dependent on these third-party providers and does not anticipate difficulties in securing alternative service providers if necessary. None of the CRO agreements permit use of the Corporation's intellectual property for their own purposes. The Corporation's research and development activities comply with regulations in Canada, Australia, and the United States. Intellectual property is protected through patent applications, trade secrets, and international patent applications filed under the Patent Cooperation Treaty (PCT).







HUGE's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Quantum Biopharma Ltd 0.00 4.56 -14.20 7
SUBTOTAL 0.00 0.00 0.00 -


Sources: Quantum Biopharma Ltd 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Quantum Biopharma Ltd ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.